ConcertAI recently launched CancerLinQ Discovery, a set of oncology-focused COVID-19 resources aimed at supporting the needs of providers, innovators, and researchers. The platform will create a linkage between de-identified clinical data and claims data to foster a more robust understanding of the patient experience by creating a prospective view of a subset of patients under active treatment. This dataset will allow stakeholders to:
- Assess incidence of COVID-19 diagnosis among oncology populations;
- Find changes in treatment patterns;
- Develop special precautions and treatment approaches based on specific treatment response and COVID-19 vulnerabilities;
- Enable new approaches to clinical research that accelerate study restarts, enable new clinical studies to be initiated, and limit onsite personnel requirements.
Read more here.
(Source: ConertAI, PRNewsWire, October 8, 2020)